Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

January 8, 2020January 8, 2020

People With IBD At Higher Risk Of Serious Viral Infections, Study Suggests

News

Adults with inflammatory bowel disease (IBD) have an increased risk of serious viral infections compared to the general population, a study suggests. This risk was found to be highest among ... Read more

October 9, 2019October 9, 2019

Interim Analysis Suggests Wider-than-expected Dosing Range for IMU-838 to Treat Ulcerative Colitis

News

Interim analysis of a Phase 2 clinical trial that’s investigating IMU-838 in people with ulcerative colitis (UC) suggests a broader dose range than initially anticipated, announced the therapy’s developer, Immunic ... Read more

October 7, 2019October 7, 2019

Diet Low in Fermented Sugars May Ease IBD Symptoms, Study Reports

News

A diet that is low in fermented sugars may help alleviate symptoms of inflammatory bowel disease (IBD), a study suggests. The study, “Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, ... Read more

September 27, 2019September 27, 2019

Innate Biologics Granted Patent for Modified Anti-inflammatory Bacterial Proteins

News

Innate Biologics has been granted a U.S. patent for its bacterial protein-based anti-inflammatory technology, the company announced in a press release. The technology is based off of bacterial E3 ubiquitin ... Read more

September 18, 2019September 17, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for IBD

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits of ... Read more

September 4, 2019September 4, 2019

Frying Oil Worsened Colon Cancer and IBD in Mice

News

Consuming frying oil may worsen colon inflammation and colon cancer, a study in mice suggests. The study, “Thermally processed oil exaggerates colonic inflammation and colitis-associated colon tumorigenesis in mice,” was ... Read more

August 28, 2019August 28, 2019

Adding Walnuts to Diet May Help to Protect Against Ulcerative Colitis, Mouse Study Suggests

News

Eating walnuts regularly may help to protect people against ulcerative colitis (UC), a study in mice suggests. But exactly how walnuts are metabolized and work in the colon is not fully ... Read more

August 26, 2019August 26, 2019

Safety Concerns Prompt Prescription Changes Among Gastroenterologists

News

A survey of gastroenterologists in the United States shows that data from the VARSITY clinical trial, as well as safety concerns about the experimental treatment Xeljanz, are affecting how some ... Read more

August 21, 2019August 21, 2019

Eli Lilly Launches Challenge for Digital Solutions to Improve IBD Care

News

The pharmaceutical company Eli Lilly has announced an open innovation challenge for individuals, teams, and organizations in the United States to propose digital health solutions that can improve care for ... Read more

July 30, 2019July 30, 2019

Clinical Trial in Israel Will Evaluate Cannabidiol-based Product for Crohn’s Disease

News

The Israel-based company Stero Biotechs announced it soon will conduct a study to test a cannabidiol (CBD)-based solution as a potential treatment for steroid-dependent Crohn’s disease (SDCD). SDCD is a ... Read more